ArticleMedical physics2026
Interpretable graph-conditioned CNNs for dose-volume histogram prediction in radiotherapy.
Article in Medical physics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundAccurate dose-volume histogram (DVH) prediction is essential for high-quality and automated radiotherapy (RT) planning. However, existing deep learning methods primarily focus on voxel-level dose prediction followed by post-processing to extract DVHs, a workflow that can introduce cumulative errors and limit clinical interpretability. PURPOSE: In this study, we propose a novel deep learning framework that directly predicts full DVHs for multiple organs-at-risk (OARs) from computed tomography (CT) and structure contours.
methodsOur method combines a three-dimensional convolutional neural network (CNN) for anatomical feature extraction with a graph neural network (GNN) that models each DVH as a structured graph, enabling sequential dose-volume dependencies to be learned explicitly. The model was extensively validated on nasopharyngeal cancer cases from an external institute and rectal cancer cases from our affiliated hospital, encompassing treatments with TomoTherapy and volumetric modulated arc therapy (VMAT). We additionally conducted a model-guided clinical DVH assessment on suboptimal cases to demonstrate the method's clinical utility
resultsThe proposed method achieved low dose-wise prediction errors and outperformed previous approach. Specifically, it reduced the mean dose error for the brain stem from 1.24 Gy to 0.66 Gy and for the larynx from 1.53 Gy to 0.78 Gy, with notable improvements also observed in the parotid glands and temporal lobes. Statistical analysis of clinical indices demonstrated non-inferiority to ground-truth plans (p > 0.05). Moreover, the predicted DVHs effectively guided plan revision and improved plan quality.
conclusionsOur results suggest that direct DVH prediction using a CNN-GNN framework offers a robust and clinically interpretable solution for treatment planning and quality assurance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.